Pet isotope pylarify f-18
Active Awarded Last action
- Contract number
- 36C24426F0056
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $433,046
Award facts
- Contract value 50% obligated
-
- $433,046.40 Current, with exercised options
- $866,092.80 Potential, with all options
- Completion date 37% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lebanon, PA 17042, USA
Award details come from SAM.gov/FPDS.
About this award
Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., was awarded a delivery order valued at $866,092.80 by Veterans Integrated Service Network 4 (VISN 4) on January 31, 2026, for the supply of PYLARIFY (piflufolastat F-18), a radioactive diagnostic imaging agent used in positron emission tomography (PET) scans for prostate cancer detection. The contract, which extends through December 31, 2027, is a firm fixed-price delivery order issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries no set-aside designation. This award represents a task order under the broader federal supply schedule established with the Department of Veterans Affairs, enabling VA medical centers to procure critical radiopharmaceutical imaging products.
The award supports the VA's medical imaging capabilities across its healthcare network, providing essential diagnostic agents for oncology applications at VA facilities within VISN 4's geographic footprint. Progenics Pharmaceuticals, as the specialized supplier of PYLARIFY radiopharmaceuticals, has established itself as a key federal contractor through multiple contract vehicles with the VA and Defense Health Agency, with some indefinite delivery vehicles carrying ceiling values exceeding $250 million. This delivery order continues the company's ongoing support of federal healthcare providers' diagnostic imaging programs and represents a continuation of the established supply relationship under the Pharmaceuticals and Drugs Federal Supply Schedule.
Quick answers
Who was awarded contract 36C24426F0056?
36C24426F0056 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on January 31, 2026.
How much is contract 36C24426F0056 worth?
The government has obligated $433,046 on 36C24426F0056. Its potential value, with all options, is $866,093.
Is contract 36C24426F0056 an order under another contract?
Yes. 36C24426F0056 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24426F0056 competed?
The extent of competition for 36C24426F0056 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award